Malt Diastase Market Report 2026

The malt diastase market size has grown strongly in recent years. It will grow from $1.46 billion in 2025 to $1.57 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increasing prevalence of digestive disorders, expansion of dietary supplement consumption, growth in enzyme applications in food processing, rising use of enzymes in animal nutrition, availability of malt-derived enzymes.

The malt diastase market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing demand for plant-based and microbial enzymes, rising innovation in enzyme formulation technologies, expansion of functional food markets, growing animal feed efficiency requirements, increasing regulatory approvals for enzyme supplements. Major trends in the forecast period include increasing use of digestive enzyme supplements, rising demand for enzyme-based food processing aids, growing adoption in animal feed applications, expansion of powder and liquid enzyme formats, enhanced focus on enzyme stability and potency.

The increasing prevalence of digestive disorders is expected to drive the growth of the malt diastase market in the coming years. Digestive disorders encompass a range of conditions affecting the gastrointestinal tract, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder, and are commonly associated with symptoms such as abdominal pain, bloating, constipation, diarrhea, heartburn, and nausea. The rise in digestive disorders is largely attributed to unhealthy dietary patterns, including high intake of processed foods, low fiber consumption, excessive sugar and fat intake, and irregular eating habits, all of which negatively impact gut health and digestive function. Malt diastase supports digestive health by breaking down complex carbohydrates into simpler sugars, thereby enhancing nutrient absorption and helping alleviate symptoms such as bloating and indigestion. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) registered in the IBD Registry exceeded 5,300, reflecting an increase of more than 3,000 compared to 2022. Therefore, the growing prevalence of digestive disorders is fueling the expansion of the malt diastase market.

Major companies operating in the malt diastase market are concentrating on the development of innovative products, such as MMC pot still malt, to boost enzymatic activity and improve brewing efficiency. MMC pot still malt is a specialized type of malt used in distillation, formulated to deliver enhanced enzymatic performance that optimizes the conversion of starches into fermentable sugars during brewing and distillation processes. For example, in August 2024, Malteurop Groupe S.A., a France-based beverage company, launched MMC Pot Still Malt for all-malt and high-malt distillation applications. Produced from carefully selected barley varieties known for high alcohol yield, the malt delivers approximately 1,000 liters of whisky at 40° per ton and is designed for the production of 100% pure malt whisky. It retains strong protein content and enzymatic activity, generating abundant fermentable sugars and ensuring consistently high spirit yields exceeding 400 liters per ton per hour.

In January 2024, Novozymes A/S, a Denmark-based biotechnology company, merged with Chr. Hansen Holding A/S to form a new entity called Novonesis, with the objective of accelerating the shift toward a climate-friendly bioeconomy. This merger combines the complementary strengths of both organizations in biotechnology and bioscience to drive innovation and growth in sustainable solutions. The newly formed company focuses on enhancing product portfolios and advancing innovation across key sectors, including agriculture, food, and healthcare. Chr. Hansen Holding A/S is a Denmark-based bioscience company specializing in natural ingredients and microbial solutions.

Major companies operating in the malt diastase market are Malt Products Corporation, DuPont de Nemours Inc., Avantor Inc., Novonesis Inc., Lallemand Inc., Briess Malt And Ingredients Co., Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Novozymes A/S, Amano Enzyme Inc., Spectrum Chemical Manufacturing Corp., Muntons plc, Philip Harris Limited, Weyermann Malting Company, Nutraceuticals International Group Inc., SUNSON Industry Group Co. Ltd., Halcyon Proteins Pty Ltd., Infinitabiotech Inc., Sunson Industry Group Co. Ltd., Velnex Medicare Pvt. Ltd.

North America was the largest region in the malt diastase market in 2025. The regions covered in the malt diastase market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the malt diastase market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The malt diastase market consists of sales of products including digestive enzyme supplements, baking enzyme blends, brewing aids, and animal feed additives. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.